| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP004060 |
|
129580-63-8 |
Satraplatin - |
0 | C10H22CL2N2O4PT | |
| CP006608 |
|
139-05-9 |
Sodium cyclohexylsulfamate - 98% |
0 | C6H12NNAO3S | |
| CP003786 |
|
63995-70-0 |
Sodium 3,3',3''-phosphinetriyltribenzenesulfonate - |
0 | C18H12NA3O9PS3 | |
| CP001143 |
|
98886-44-3 |
Fosthiazate - |
0 | C9H18NO3PS2 | |
| CP007325 |
|
69377-81-7 |
2-((4-Amino-3,5-dichloro-6-fluoropyridin-2-yl)oxy)acetic acid - 97% |
0 | C7H5CL2FN2O3 | |
| CP000741 |
|
24939-03-5 |
Polyinosinic acid-polycytidylic acid；P I : PC - 50% |
0 | C10H13N4O8P.C9H14N3O8P | |
| CP002118 |
![Maropitant citrate [USAN]](/image/12071)
|
359875-09-5 |
Maropitant citrate [USAN] - 98% |
0 | C32H40N2O.C6H8O7.H2O | |
| CP002947 |
|
83701-22-8 |
minoxidil sulfate - 99% |
0 | C9H17N5O5S | |
| CP001678 |
|
5328-37-0 |
L-Arabinose；L-(+)-Arabinose - 99% |
0 | C5H10O5 | |
| CP005721 |
|
25122-57-0 |
clobetasone butyrate - 97.0%~102.0% |
0 | C26H32CLFO5 | |
| CP007235 |
|
358-23-6 |
PFC-MSA - 99.5% |
0 | C2F6O5S2 | |
| CP007917 |
|
1405-10-3 |
Neomycin Sulphate - 650u/mg |
0 | C23H46N6O13.3(H2SO4);C23 | |
| CP000433 |
|
616-91-1 |
N-Acetylcysteine；N-Acetyl-L-Cysteine - 98% |
0 | C5H9NO3S | |
| CP002778 |
|
122628-50-6 |
1H-Pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylicacid, 4,5-dihydro-4,5-dioxo-, sodium salt (1:2) - 98% |
0 | C14H4N2NAO8 | |
| CP005828 |
|
72619-32-0 |
(R)-Methyl 2-(4-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)phenoxy)propanoate - |
0 | C16H13CLF3NO4 | |
| CP004261 |
|
69327-76-0 |
Buprofezin - 98% |
0 | C16H23N3O2S | |
| CP001285 |
|
53746-45-5 |
Fenoprofen calcium - 97.0~103.0% |
0 | C30H30CaO8 | |
| CP001014 |
|
3650-09-7 |
Carnosic acid - |
0 | C20H28O4 | |
| CP001232 |
|
102690-88-0 |
Phosphoramidous acid,N,N-bis(1-methylethyl)-, bis(2-cyanoethyl) ester - 99% |
0 | C12H22N3O2P | |
| CP001566 |
|
3095-95-2 |
2-(Diethoxyphosphoryl)acetic acid - |
0 | C6H13O5P | |
